Chelerythrine, a specific PKC inhibitor, blocks acquisition but not consolidation and retrieval of conditioned taste aversion in rat.
Association of the short-term memory of the gustatory conditioned stimulus (CS) with visceral malaise (unconditioned stimulus, US) in conditioned taste aversion (CTA) paradigm takes place in the parabrachial nuclei (PBN) of brainstem. In order to ascertain the role of protein-kinase C (PKC) during different phases of CTA acquisition and retrieval, four experimental series were carried out. In Experiment 1, 1 microl of 10 mM of PKC inhibitor chelerythrine prevented CTA acquisition when applied into PBN in the CS-US interval. In Experiment 2, the necessity of PKC activity in different phases of CTA acquisition was tested by prolonging the time interval between PBN administration of chelerythrine and i.p. LiCl. CTA acquisition was prevented when chelerythrine-induced blockade of PKC coincided with GSTM persistence but not with CTA consolidation. In Experiment 3, the interval between saccharin drinking and LiCl injection was prolonged to 120 min. Again, chelerythrine blockade of PKC activity prevented CTA formation when it interfered with GSTM persistence. In Experiment 4, the possibility that PKC activity is necessary also for CTA retrieval was tested by chelerythrine application into PBN 5 min before retrieval testing. In this case, the chelerythrine-induced PKC blockade did not impair CTA retrieval. It is concluded that PKC is important for GSTM formation and persistence but not for CTA consolidation or retrieval.
Institute of Physiology, Academy of Sciences, Prague, Czech Republic.
B
B
Sacchetti
E
E
Bielavska
D000470:Alkaloids; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D053119:Benzophenanthridines; D001933:Brain Stem / Q000187:drug effects / Q000502:physiology; D003213:Conditioning, Psychological / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007267:Injections; D008297:Male; D008570:Memory, Short-Term / Q000187:drug effects; D010617:Phenanthridines / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D051381:Rats; D011919:Rats, Inbred Strains; D013649:Taste / Q000502:physiology*
D000470:Alkaloids; D053119:Benzophenanthridines; D004791:Enzyme Inhibitors; D010617:Phenanthridines; C016299:chelerythrine; D011493:Protein Kinase C